CNTB

Connect Biopharma Holdings Limited is a biotechnology company in the healthcare sector with a market capitalization of $134.17 million and 62 employees. The company's industry classification remains undefined within the provided information. The financial health of Connect Biopharma Holdings Limited indicates significant challenges, with net income of -$49.28 million and EBITDA of -$54.69 million in the trailing twelve months. Gross margin is 100.0%, but operating margin stands at -110481.2% and profit margin is 0.0%. Returns on equity and assets are also negative at -66.8% and -38.7%, respectively, while debt to equity ratio is 1.41. The company maintains a cash balance of $54.78 million against minimal debt of $781,000. The valuation context for Connect Biopharma Holdings Limited presents a mix of indicators. Forward P/E stands at -2.95 and Price to Book is 2.42, while Price to Sales reaches 176.07 and EV/EBITDA falls at -1.59. Revenue growth year-over-year has been substantial, contracting by -98.7%.